Approved with
change as agreed upon in memo to OMB on June 20, 2003 (e-mail
attached).
Inventory as of this Action
Requested
Previously Approved
06/30/2006
06/30/2006
900
0
0
175
0
0
0
0
0
The CDC is conducting a performance
evaluation program and testing practice surveys to assess and
evaluate the relationships between laboratory practices and
performance in sites performing the new HIV rapid tests. The advent
of the new HIV rapid tests onto the U.S. market is likely to change
the spectrum of HIV testing in the U.S. Since the most popular
test, the OraQuick HIV Rapid Test (OraSure Technologies, Inc.) is
waived under CLIA, the tests will be done in nontraditional testing
sites and often by persons not trained in testing quality
assurance. Due to the........
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.